New noncovalent inhibitors of penicillin-binding proteins from penicillin-resistant bacteria

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Turk, Samo ^a   Verlaine, Olivier ^b   Gerards, Thomas ^b   Živec, Matej ^a   Humljan, Jan ^a,c   Sosič, Izidor ^a   Amoroso, Ana ^b   Zervosen, Astrid ^b   Luxen, André ^b   Joris, Bernard ^b   Gobec, Stanislav ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c Lek Pharmaceuticals dd   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

2 (3 PROPOXYBENZAMIDO)BENZOIC ACID; 2 (4 PROPOXYBENZAMIDO)BENZOIC ACID; 2 (6 BUTOXYNAPHTHALENE 2 SULFONAMIDO)BENZOIC ACID; 3 (QUINOLINE 8 SULFONAMIDO)BENZAMIDE; 4 (4 ETHOXYPHENYLSULFONAMIDO)BENZOIC ACID; 4 [N (4 ETHOXYPHENYL)SULFAMOYL]BENZOIC ACID; 5 BROMO 2 (3 PROPOXYBENZAMIDO)BENZOIC ACID; 5 BROMO 2 (4 PROPOXYBENZAMIDO)BENZOIC ACID; 5 HYDROXY 2 (3 PROPOXYBENZAMIDO)BENZOIC ACID; 5 HYDROXY 2 (4 PROPOXYBENZAMIDO)BENZOIC ACID; 5 METHYL 2 (3 PROPOXYBENZAMIDO)BENZOIC ACID; AGENTS AFFECTING PROTEIN METABOLISM; N (4 HYDROXYPHENYL)QUINOLINE 8 SULFONAMIDE; PENICILLIN BINDING PROTEIN; PROTEIN INHIBITOR; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; PBP 2X PROTEIN, STREPTOCOCCUS; PENICILLIN BINDING PROTEIN 2A, STREPTOCOCCUS; PENICILLIN DERIVATIVE; PENICILLIN-BINDING PROTEIN 2A, STREPTOCOCCUS; PEPTIDE SYNTHASE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG SCREENING; DRUG STRUCTURE; ENTEROCOCCUS FAECIUM; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; STREPTOCOCCUS PNEUMONIAE; STRUCTURE ACTIVITY RELATION; ANTIBIOTIC RESISTANCE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; GRAM POSITIVE BACTERIUM; METABOLISM; MICROBIOLOGICAL EXAMINATION;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS FAECIUM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; POSIBACTERIA; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS FAECIUM; GRAM-POSITIVE BACTERIA; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; PENICILLIN-BINDING PROTEINS; PENICILLINS; PEPTIDE SYNTHASES; STREPTOCOCCUS PNEUMONIAE;

EID: 79955791666     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019418     Document Type: Article

References (25)

1. Macheboeuf P, Contreras-Martel C, Job V, Dideberg O, Dessen A, (2006) Penicillin binding proteins: key players in bacterial cell cycle and drug resistance processes. FEMS Microbiol Rev 30: 673-691.
2. Wilke MS, Lovering AL, Strynadka NCY, (2005) Beta-lactam antibiotic resistance: a current structural perspective. Curr Opin Microbiol 8: 525-533.
3. Chambers HF, (1997) Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev 10: 781-791.
4. Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, et al. (2002) The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci U S A99: 7687-7692.
5. Wu SW, de Lencastre H, Tomasz A, (2000) Recruitment of the mecA gene homologue of Staphylococcus sciuri into a resistance determinant and expression of the resistant phenotype in Staphylococcus aureus. J Bacteriol 183: 2417-2424.
6. Lim D, Strynadka N, (2002) Structural basis for the beta lactam resistance of PBP2a from methicillin-resistant Staphylococcus aureus. Nat Struct Biol 9: 870-876.
7. Toney JH, Hammond GG, Leiting B, Pryor KA, Wu JK, et al. (1998) Soluble penicillin-binding protein 2a: beta-lactam binding and inhibition by non-beta-lactams using a 96-well format. Anal Biochem 255: 113-119.
8. Zervosen A, Lu WP, Chen Z, White RE, Demuth TP, et al. (2004) Interactions between penicillin-binding proteins (PBPs) and two novel classes of PBP inhibitors arylalkylidene rhodanines and arylalkylidene iminothiazolidin-4-ones. Antimicrob Agents Chemother 48: 961-969.
9. Miguet L, Zervosen A, Gerards T, Pasha FA, Luxen A, et al. (2009) Discovery of new inhibitors of resistant Streptococcus pneumoniae penicillin binding protein (PBP) 2x by structure-based virtual screening. J Med Chem 52: 5926-5936.
10. Irwin JJ, Shoichet BK, (2005) ZINC - A free database of commercially available compounds for virtual screening. J Chem Inf Model 45: 177-182.
11. Rarey M, Stahl M, (2001) Similarity searching in large combinatorial chemistry spaces. J Comput Aid Mol Des 15: 497-520.
12. Carapito R, Chesnel L, Vernet T, Zapun A, (2005) Pneumococcal beta-lactam resistance due to a conformational change in penicillin-binding protein 2x. J Biol Chem 281: 1771-1777.
13. Sauvage E, Kerff F, Fonzé E, Herman R, Schoot B, et al. (2002) The 2.4-Å crystal structure of the penicillin-resistant penicillin-binding protein PBP5fm from Enterococcus faecium in complex with benzylpenicillin. Cell Mol Life Sci 5: 1223-1232.
14. Shoichet B, (2006) Screening in a spirit haunted world. Drug Discovery Today 11: 607-615.
15. Rarey M, Kramer B, Lengauer T, Klebe G, (1996) A fast flexible docking method using an incremental construction algorithm. J Mol Biol 261: 470-489.
16. Dessen A, Mouz N, Gordon E, Hopkins J, Dideberg O, (2001) Crystal structure of PBP2x from a highly penicillin-resistant Streptococcus pneumoniae clinical isolate: a mosaic framework containing 83 mutations. J Biol Chem 276: 45106-45112.
17. Humljan J, Kotnik M, Contreras-Martel C, Blanot D, Urleb U, et al. (2008) Novel naphthalene-N-sulfonyl-D-glutamic acid derivatives as inhibitors of MurD a key peptidoglycan biosynthesis enzyme. J Med Chem 51: 7486-7494.
18. Lemaire S, Glupczynski Y, Duval V, Joris B, Tulkens PM, et al. (2009) Activities of ceftobiprole and other cephalosporins against extracellular and intracellular (THP-1 macrophages and keratinocytes) forms of methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 53: 2289-2297.
19. Feng BY, Shoichet BK, (2006) A detergent-based assay for the detection of promiscuous inhibitors. Nat Protoc 1: 550-553.
20. Lakaye B, Damblon C, Jamin M, Galleni M, Lepage S, et al. (1994) Synthesis purification and kinetic properties of fluorescein-labelled penicillins. Biochem J 300: 141-145.
21. Adam M, Damblon C, Jamin M, Zorzi W, Galleni M, et al. (1990) Chromogenic depsipeptide substrates for beta-lactamases and penicillin-sensitive DD-peptidases. Biochem J 270: 525-529.
22. Schwyzer R, Hurlimann C, (1954) Coenzym A: Modellreaktionen zur enzymatischen Aktivierung von Acylderivaten des Coenzyms A. Helv Chim Acta 37: 155-166.
23. Macheboeuf P, Fischer DS, Brown T Jr, Zervosen A, Luxen A, et al. (2007) Structural and mechanistic basis of penicillin-binding protein inhibition by lactivicins. Nature Chem Biol 9: 565-569.
24. Clinical and Laboratory Standards Institute (CLSI) Methods for dilution Antimicrobial Susceptibility Tests for Bacteria that growth aerobically; Approved standard. Eighth Edition(2009) M7 A8 Vol. 29 (No 2)
25. European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution. E. Dis. (2003) 5.1